Article info

Download PDFPDF
Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain

Authors

  1. Reprint requests: Daniel B. Carr, M.D., Chief Medical Officer, Javelin Pharmaceuticals, Inc. 125 Cambridge Park Drive, Cambridge, MA 02140. E-mail: dcarr{at}javelinpharmaceuticals.com

Citation

Leeson RM, Harrison S, Ernst CC, et al
Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain

Publication history

  • First published July 1, 2007.
Online issue publication 
February 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.